Fatma Uçar

Fatma Uçar

Auto-generated profile, based on publicly available information

Fatma Uçar

Department of Biochemistry, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
AOAlpaslan Ozturk
Alpaslan Ozturk
ITIsmail Temel
Ismail Temel
AYAli Yalcindag
Ali Yalcindag
FUFatma Ucar
Fatma Ucar
FYFatih Yay
Fatih Yay
Objectives: This study aimed to verify the enzymatic ethanol analysis method and compare the technique with headspace gas chromatography (HS/GC). Methods: The limit of the blank, limit of detection, and limit of quantification, precision, linearity, and accuracy of the enzymatic process were evaluated based on the data obtained. In addition, a method comparison was made between the enzymatic method and the HS/GC analysis method. Results: It was seen that the enzymatic method was linear in the range of 14–450 mg/dL, the coefficient of variation and bias values ranged between 0.5–1.09% and 4.52–9.78%, respectively. The quantitative accuracy was 2.13% and 2.23% at concentrations of 41.16 and 95.82 mg/dL, respectively. When the regression analysis was performed between the results obtained using the enzymatic alcohol dehydrogenase (ADH) and HS/GC methods, y=0.966x + 2.084 linear relationship formula and regression coefficient of r 2 =0.9987, it was found that it showed a good agreement at a confidence interval of 5%. Conclusions: The findings showed that the enzymatic method had good linearity, excellent precision, and a high correlation with the higher-order comparator method, the HS/GC method, in the ethanol analysis.

1 October 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
EUEren Usul
Eren Usul
SOSeda Ozkan
Seda Ozkan
MHMehmet Hilmi Höke
Mehmet Hilmi Höke
AKAynur Ecevit Kaya
Aynur Ecevit Kaya
FUFatma Ucar
Fatma Ucar
TCTolga Cimen
Tolga Cimen

13 September 2014 in Journal of Experimental and Clinical Medicine
Verified
Journal Article
Open access
PDF file
FUFatma Uçar
Fatma Uçar
SASumeyya Akyol
Sumeyya Akyol
GOGulfer Ozturk
Gulfer Ozturk
ZGZeynep Ginis
Zeynep Ginis
GEGonul Erden
Gonul Erden
Tuncay DelibasiTuncay Delibasi
Tuncay Delibasi
Evaluation of serum vitamin D levels in elderly patients with subclinical hypothyroidism

6 April 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
NANalan Meti̇n Aksu
Nalan Meti̇n Aksu
DADuygu Yazgan Aksoy
Duygu Yazgan Aksoy
MAMeltem Akkaş
Meltem Akkaş
NÇNese Çinar
Nese Çinar
FUFatma Uçar
Fatma Uçar
AUAydan Usman
Aydan Usman
Background/aim: Acute hyperglycemia is generally a frequently encountered condition in the emergency department (ED), because it is seen as a complication of diabetes mellitus (DM). In this study, we aimed to detect the change in adiponectin levels during acute hyperglycemic states and after normalization of blood glucose with insulin treatment. Materials and methods: Forty-eight patients over the age of 18 years who were admitted to the ED with acute hyperglycemia were included in the study. Serum samples were taken from patients on admission and 6 h after the normalization of blood glucose with insulin treatment, and adiponectin levels were measured in both samples. Results: There were 21 female and 27 male patients with a median age of 58.7 +/- 18 years. All patients' blood glucose levels were normalized with insulin treatment according to international recommendations. Serum adiponectin levels decreased significantly after the normalization of blood glucose in the whole group. Adiponectin levels decreased from 28.9 +/- 16.5 to 12.1 +/- 10.9 mu g/mL (P < 0.0001) in the whole group. This decrease was independent of diabetes type and body mass index. Conclusion: Normalization of blood glucose in patients with hyperglycemia caused a decrease in adiponectin levels, independent of diabetes type and/or body weight in an acute emergency setting. Inhibited upregulation of adiponectin secretion and/or blunted suppressive effect of insulin due to hyperglycemia or exogenous insulin administration may have caused the decrease in adiponectin levels.

3 September 2021 in Acta Medica
Verified
Journal Article
Open access
PDF file
DTDilara Bal Topcu
Dilara Bal Topcu
AOAhmet Ozsoy
Ahmet Ozsoy
FUFatma Ucar
Fatma Ucar
AYAli Yalcindag
Ali Yalcindag
YOYesim Oztas
Yesim Oztas
Objectives: The primary purpose of medical laboratories is to provide the most accurate results appropriate to the patient's medical condition. Therefore, the reliability of each laboratory must be scientifically tested. Approximately 10% of laboratory errors occur in the analytical phase. In this study, we aimed to evaluate analytical process performances of 14 routinely assayed parameters according to six sigma methodology. Materials and Methods: Mean, standard deviation and coefficient of variation were calculated from internal quality control data for three months from 14 routinely assayed parameters (albumin, alanine aminotransferase, aspartate aminotransferase, chloride, creatinine, glucose, HDL cholesterol, lactate dehydrogenase, potassium, total cholesterol, total protein, sodium, triglyceride and urea) in the laboratory (Roche Cobas c501). Bias was calculated using external quality control values for same months. Total error was also calculated. Acceptable total error was determined according to the Clinical Laboratory Improvement Amendments and Turkey criteria. Sigma values were calculated and divided into four groups; as 6 world-class performance. Results: According to the Clinical Laboratory Improvement Amendments and Turkey sigma assessment, first levels of chloride, total cholesterol, glucose and urea performance were unacceptable. Moreover according to the Clinical Laboratory Improvement Amendments sigma assessment, first levels of albumin, creatinine, total protein; and both levels of sodium, chloride and urea were unacceptable. Other tests were found to be suited for purpose, acceptable or world-class performance. Conclusions: Sigma measurements should be routinely performed in laboratories for evaluating the analytical period performance of the laboratory. That will increase its quality via regulatory preventive actions. Our study allowed us to see and improve our measurement quality by determining the three-month periodic performance of our laboratory tests.

22 October 2021 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
YDYakup Dülgeroğlu
Yakup Dülgeroğlu
GEGönül Erden
Gönül Erden
MEMusa Eki̇ci̇
Musa Eki̇ci̇
AYAhmet Yeşi̇lyurt
Ahmet Yeşi̇lyurt
ÖOÖner Odabaş
Öner Odabaş
GÖGülfer Öztürk
Gülfer Öztürk
Objective: In this study aimed to determine the diagnostic efficiency of miR-21 and miR-34a serum levels in the discrimination of benign prostatic hyperplasia, chronic prostatitis, and prostate cancer. Materials and Methods: Blood samples were taken from 70 patients (25 benign prostatic hyperplasias, 10 chronic prostatitides, and 35 prostate cancer) who underwent prostate needle biopsy. After obtaining serum under suitable conditions, RNA isolation, cDNA synthesis, and qRT-PCR analysis were performed using Qiagen brand kits on Rotor-Gene® Q (Qiagen, Germany) device. -∆Ct values ​​were calculated using RNU6 as a reference gene for normalization. -∆Ct values ​​were used in all statistical calculations. Results: It was observed that miR-21 serum levels were upregulated in chronic prostatitis and cancer groups compared to benign prostatic hyperplasia and the difference between the groups was statistically significant (p = 0.021 and p = 0.001, respectively). The specificity and sensitivity of miR-21 and miR-21/miR-34a combination was calculated as 56% and 86%; 84% and 71% in discriminating benign prostatic hyperplasia and prostate cancer groups, respectively. Conclusion: In this study, it has been shown that miR-21 and miR-21/miR-34a combination has diagnostic performance that can be a biomarker candidate in diagnosing prostate cancer. In addition, the presence of a gradual increase in chronic prostatitis and prostate cancer at miR-21 levels compared to benign prostatic hyperplasia suggests that inflammation and cancer transformation processes taking place at the molecular level are also reflected in the circulating microRNA profile. Keywords: Prostate cancer, Prostatitis, Benign prostatic hyperplasia, MicroRNA, Diagnostic efficiency